Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Statins have no clinical benefit in pneumonia

  • Comment
Statin users admitted to hospital for pneumonia are no less likely to die or be admitted to an intensive care unit than non users, according to new Canadian research.

Statin users admitted to hospital for pneumonia are no less likely to die or be admitted to an intensive care unit than non users, according to new Canadian research.

The findings cast doubt on recent observational studies that have reported that patients taking statins at the time they develop pneumonia are less likely to suffer sepsis, die from sepsis or need admitting to ICU.

This latest study looked at 3,415 patients with community acquired pneumonia admitted at six hospitals in Canada and compared the inpatientdeath rates and admission to ICUbetween those taking statinsand those that were not.

Findings show that statin users were less likely to die or be admitted to ICU than non-users 15% compared with 19%. However the potential benefit was outweighed by the potential harm, teh authors concluded.

They suggest anyreduced death rates amongst statin users may be because the drug is more likely to be prescribed to healthy or health seeking patients.

British Medical Journal(2006). Online Publication. DOI:10.1136/bmj.38992.565972.7C

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.